Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.3800-0.1700 (-6.67%)
At close: 04:00PM EST
2.3700 -0.01 (-0.42%)
After hours: 07:50PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.5500
Open2.5200
Bid2.3600 x 1000
Ask2.3900 x 800
Day's Range2.3600 - 2.5100
52 Week Range1.3100 - 15.5500
Volume95,790
Avg. Volume1,333,909
Market Cap19.92M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BIAF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • bioAffinity Technologies, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
Advertisement
Advertisement